Skip to main content

Table 2 Impact of early hysterectomies due to bleeding on the effect of tranexamic acid

From: The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial

Exclusion interval (hours from randomisation)

Exclusionsa

N

Death due to bleeding

TXA (%)

Placebo (%)

TXA

Placebo

TXA (%)

Placebo (%)

Risk ratio (99% CI)

None

7494

7384

188 (2.5)

195 (2.6)

0.95 (0.73–1.23)

1

90 (1.2)

93 (1.3)

7404

7291

112 (1.5)

117 (1.6)

0.94 (0.67–1.32)

2

175 (2.3)

167 (2.3)

7319

7217

42 (0.6)

64 (0.9)

0.65 (0.39–1.08)

3

205 (2.7)

214 (2.9)

7289

7170

23 (0.3)

34 (0.5)

0.67 (0.33–1.33)

4

217 (2.9)

236 (3.2)

7277

7148

19 (0.3)

25 (0.4)

0.75 (0.34–1.63)

5

227 (3.0)

246 (3.3)

7267

7138

16 (0.2)

20 (0.3)

0.79 (0.33–1.86)

  1. a% is the proportion of the original trial arm excluded (N = 7494 TXA, N = 7384 placebo). TXA = tranexamic acid. Includes women treated within 3 h of delivery only